Wuxi Bio (02269) repurchased 3.269 million shares on June 12 at a cost of HK$99.7766 million.

Wuxi Bio (02269) announced that on June 12, 2026, it repurchased 3.269 million shares at a cost of HK$99.7766 million.

Zhitong FinanceJun 12 22:52

Wuxi Biologics (Cayman) Stock Climbs 3.8% in Hong Kong

Dow JonesJun 12 16:30

June 11 Share Buyback Summary | Tencent and Xiaomi Group-W among companies conducting buybacks, with Tencent spending HK$5.01 billion

According to a filing disclosed by the Hong Kong Exchange on June 12, Tencent (00700.HK), Xiaomi Group-W (01810.HK), and others repurchased shares. ① Tencent (00700.HK) repurchased 1.083 million ordinary shares on June 11, amounting to HK$501 million, at prices ranging from HK$455 to HK$475.2 per share. Since the adoption of the share repurchase mandate, the cumulative number of securities repurchased has reached 18.3971 million shares, representing 0.20177% of the issued share capital as of the date the ordinary resolution was passed. ② Xiaomi Group-W (01

Futu NewsJun 12 09:30

Wuxi Bio (02269) repurchased 3.388 million shares on June 11 at a cost of HK$99.8197 million.

Wuxi Bio (02269) announced that on June 11, 2026, it repurchased 3.388 million shares at a cost of HK$99.8197 million.

Zhitong FinanceJun 11 21:45

WUXI BIO(2269.HK):COMMERCIALIZATION PATH BECOMES CLEARER GLOBAL LANDSCAPE ENTERS REBALANCING PHASE

Jun 11 20:26

Hong Kong Stock Ratings Summary: China Galaxy Securities has assigned Alibaba a 'Recommended' rating.

Cailian Press will regularly compile ratings and target prices from various institutions for Hong Kong stocks.

cls.cnJun 11 15:09